Johns Hopkins ABX Guide
Ceftizoxime
Ceftizoxime is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- No longer available in the U.S.
- Lower respiratory tract infections
- Urinary tract infections
- Gonorrhea including uncomplicated cervical and urethral gonorrhea
- Pelvic inflammatory disease caused by N. gonorrhoeae, E. coli or S. agalactiae
- Intra-abdominal infections (author’s comment: avoid in severe intra-abdominal infections)
- Septicemia caused by S. pneumoniae, MSSA, E. coli,Bacteroides spp. including B. fragilis, Klebsiella spp. and Serratia spp. (must confirm sensitivity)
- Skin and skin-structure infections (not MRSA)
- Bone and joint infections
- Meningitis caused by H. influenzae (limited data with S. pneumoniae)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- No longer available in the U.S.
- Lower respiratory tract infections
- Urinary tract infections
- Gonorrhea including uncomplicated cervical and urethral gonorrhea
- Pelvic inflammatory disease caused by N. gonorrhoeae, E. coli or S. agalactiae
- Intra-abdominal infections (author’s comment: avoid in severe intra-abdominal infections)
- Septicemia caused by S. pneumoniae, MSSA, E. coli,Bacteroides spp. including B. fragilis, Klebsiella spp. and Serratia spp. (must confirm sensitivity)
- Skin and skin-structure infections (not MRSA)
- Bone and joint infections
- Meningitis caused by H. influenzae (limited data with S. pneumoniae)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: December 6, 2017
Citation
Dzintars, Kathryn, and Paul A Pham. "Ceftizoxime." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540103/all/Ceftizoxime.
Dzintars K, Pham PA. Ceftizoxime. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540103/all/Ceftizoxime. Accessed May 26, 2022.
Dzintars, K., & Pham, P. A. (2017). Ceftizoxime. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540103/all/Ceftizoxime
Dzintars K, Pham PA. Ceftizoxime [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2022 May 26]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540103/all/Ceftizoxime.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ceftizoxime
ID - 540103
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/12/06/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540103/all/Ceftizoxime
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
